Latest Research in Effects and risks of endocrine disrupting chemicals

Top Research Topics in Effects and risks of endocrine disrupting chemicals

• Gut microbiota and health — 5 papers
• Drug Transport and Resistance Mechanisms — 4 papers
• Effects and risks of endocrine disrupting chemicals — 1 papers
• Celiac Disease Research and Management — 1 papers
• Bioactive Compounds and Antitumor Agents — 1 papers
• Bone Metabolism and Diseases — 1 papers
• Liver Diseases and Immunity — 1 papers
• Alcohol Consumption and Health Effects — 1 papers
• Adipokines, Inflammation, and Metabolic Diseases — 1 papers
• Kidney Stones and Urolithiasis Treatments — 1 papers

Highest-Cited Papers

1. Lithocholic acid attenuates intestinal mucosal epithelial inflammation and apoptosis associated with bile deficiency through the VDR/IAP axis
2. Integrated multi-omics and experimental analyses reveal VIPR1 as a potential mediator linking environmental bisphenol A exposure to MASH-HCC progression
3. Axial Connectivity of the Lung Microbiome: A Review of Interorgan Crosstalk
4. The gut-liver axis as initiator of celiac disease
5. Benzo[a]pyrene-derived quinones exploit mitochondrial electron transport to drive catalytic redox cycling and potent ROS amplification
6. Decoding the Biological Function of Bile Acids for Drug Discovery
7. Gut microbiome and metabolome profiles in diverse etiologies of chronic liver disease
8. Gut Microbiota‐Derived Indole‐3‐Propionic Acid Alleviates Diabetic Osteoporosis Through Nrf2‐Mediated Ferroptosis Suppression
9. Bile acid sequestration reveals microbiome remodeling that dominates FXR signaling to shape host responses to enteric infection
10. Gut microbiota-derived imidazole propionate promotes primary sclerosing cholangitis via p38 signalling
11. Bile Acid Metabolism as a Unifying Readout for Diet, Microbiome Function, and Gastrointestinal Disease
12. The Polysaccharides from Balanophora harlandii Hook. Alleviated Alcoholic Steatohepatitis via Suppressing Bile Acid Synthesis Mediated by Intestinal FXR Activation
13. Unveiling the mechanism of metabolites derived from gut microbiota in the treatment of acute kidney injury via network pharmacology and bioinformatics
14. Considerations for the dynamic role of bile acids during oral drug discovery and development
15. A macrophage-conditioned medium model recapitulates inflammation-associated suppression of UCP-1 expression in KK-Ay mice
16. Differences in gut microbiota between septic patients and non-septic individuals
17. Gut Microbiota‐Isoallolithocholic Acid Crosstalk Promotes Calcium Oxalate Kidney Stone Formation via PARP1‐Mediated Parthanatos
18. Exploring the therapeutic Potential of multi target actions via metformin against Epilepsy through Network Pharmacology